Patient-reported, Health Economic and Psychosocial Outcomes in Friedreich Ataxia

Recruiting Observational Study
Friedreich Ataxia
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
12 and older
Sex
Any
Study type
Observational
Participants needed
200 (estimated)
Sponsor
German Center for Neurodegenerative Diseases (DZNE) · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The PROFA study is an international, multi-centric observational and validation study to assess the patient-reported, psychosocial and economic outcomes of patients with Friedreich Ataxia (FA). Eligible patients will be recruited from six study centers in Germany, Austria and France. Patients will complete a baseline assessment via face-to-face interviews at the study centers and multiple momentar…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * FA confirmed by molecular genetic testing * Ataxia severity of ≤30 points according to the Scale of the Assessment and Rating of Ataxia (SARA) * Access to a smartphone or tablet and able to operate the device * Older than 12 years Exclusion Criteria: * Lack of ability to giv…
Contacts

Bernhard Michalowsky, PD Dr.

+49 3834 868530

bernhard.michalowsky@dzne.de

CONTACT

Maresa Buchholz, Dr.

+49 3834 868534

maresa.buchholz@dzne.de

CONTACT